Study endpoint
The study endpoint was the safety outcomes including thromboembolic
events and bleeding complications during the procedure and 30 days
following CBA. Thromboembolism was diagnosed by a combination of both
the clinical situation and radiologic studies. Thromboembolic events
were defined as stroke, transient ischemic attack (TIA), or systemic
embolism (SE). Bleeding complications were defined as any
procedure-related bleeding.